Yu Shan
Founder bij SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.
Vermogen: 54 M $ op 31-03-2024
Profiel
Yu Shan richtte Shenzhen Hepalink Pharmaceutical Group Co., Ltd op. Momenteel is hij General Manager & Executive Director bij Shenzhen Hepalink Pharmaceutical Group Co., Ltd. en Executive Partner bij Urumqi Shuidishichuan Equity Investment Partnership LP. Hij zit ook in de raad van bestuur van Chengdu Hepatunn Pharmaceutical Co. Ltd. en Shenzhen Duopule Industrial Development Co., Ltd. Hij is afgestudeerd aan de Universiteit van Peking.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-06-2023 | 46 425 600 ( 3.72% ) | 54 M $ | 31-03-2024 |
Actieve functies van Yu Shan
| Bedrijven | Functie | Begin |
|---|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Founder | 21-04-1998 |
| Urumqi Shuidishichuan Equity Investment Partnership LP | Corporate Officer/Principal | - |
Chengdu Hepatunn Pharmaceutical Co. Ltd.
 Chengdu Hepatunn Pharmaceutical Co. Ltd. Chemicals: Major DiversifiedProcess Industries Part of Pangu Chenchen (Shanghai) Enterprise Management Center LP, Chengdu Hepatunn Pharmaceutical Co. Ltd. manufactures and distributes injections and creams. The private company is based in Chengdu, China. Chengdu Hepatunn Pharmaceutical Co. was acquired by Pangu Chenchen (Shanghai) Enterprise Management Center LP from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on July 14, 2018 for $5.32 million. | Director/Board Member | - |
Shenzhen Duopule Industrial Development Co., Ltd.
 Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Part of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Duopule Industrial Development Co., Ltd. distributes biochemical products. The private company is based in Shenzhen, China. Shenzhen Duopule Industrial Development Co. was acquired by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on May 31, 2017 for $414.58 million. | Director/Board Member | 13-01-2014 |
Opleiding van Yu Shan
| Peking University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| Urumqi Shuidishichuan Equity Investment Partnership LP | |
Chengdu Hepatunn Pharmaceutical Co. Ltd.
Chengdu Hepatunn Pharmaceutical Co. Ltd. Chemicals: Major DiversifiedProcess Industries Part of Pangu Chenchen (Shanghai) Enterprise Management Center LP, Chengdu Hepatunn Pharmaceutical Co. Ltd. manufactures and distributes injections and creams. The private company is based in Chengdu, China. Chengdu Hepatunn Pharmaceutical Co. was acquired by Pangu Chenchen (Shanghai) Enterprise Management Center LP from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on July 14, 2018 for $5.32 million. | Process Industries |
Shenzhen Duopule Industrial Development Co., Ltd.
Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Part of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Duopule Industrial Development Co., Ltd. distributes biochemical products. The private company is based in Shenzhen, China. Shenzhen Duopule Industrial Development Co. was acquired by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on May 31, 2017 for $414.58 million. | Distribution Services |
